© 2004 European Society of Cardiology
Accuracy of a 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography: a systematic review and meta-analysis*
a Department of Health Sciences, Division of General Practice and Primary Health Care, University of Leicester, Leicester General Hospital Gwendolen Road, Leicester LE5 4PW, UK
b Department of Medicine and Therapeutics, University of Leicester UK
* Corresponding author. Tel.: +44-116-258-4367; fax: +44-116-258-4982. E-mail address: kk22{at}le.ac.uk
 |
Abstract |
|---|
Aim: The aim of this study was to examine the usefulness of 12-lead electrocardiogram in screening patients with suspected heart failure for open access echocardiography. We carried out a systematic review and meta-analysis of published observational studies. Published studies were identified in the Medline and Embase databases, this was supplemented by key texts, personal reference collections and examining the cited references in the above sources. English language articles in which patients were referred from primary care with a presumptive diagnosis of heart failure to an open access echocardiography service were reviewed. We included studies that reported both electrocardiography findings and echocardiography as a reference standard. Primary outcome measures were sensitivity and specificity, metaanalysed simultaneously to produce a Summary Receiver Operating Characteristic (SROC) curve.
Results: Four trials were identified which satisfied the inclusion criteria, including 1419 people with a potential diagnosis of heart failure referred for open access echocardiography. Estimates of sensitivity and specificity varied greatly in individual studies. The area under the SROC curve was 0.84 (95% CI: 0.33 to 1.00).
Conclusion: A 12-lead electrocardiogram is an inadequate screening tool for identifying patients with suspected heart failure who require echocardiography. Further research is required to determine the usefulness of other screening strategies including B-type natriuretic peptide in screening patients with suspected heart failure who need referral for open access echocardiography.
Received February 23, 2004; Accepted March 3, 2004
Contributors: KK initiated the study. KK conducted the searches and KK and IS extracted the data. KA and AS analysed the data. All authors participated in discussing the results and writing the paper. KK will act as guarantor for the paper.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. K. Khan, K. M. Goode, J. G.F. Cleland, A. S. Rigby, N. Freemantle, J. Eastaugh, A. L. Clark, R. de Silva, M. J. Calvert, K. Swedberg, et al. Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge Eur J Heart Fail, May 1, 2007; 9(5): 491 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. I.W. Galasko, S. C. Barnes, P. Collinson, A. Lahiri, and R. Senior What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur. Heart J., January 2, 2006; 27(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|